Study details
Enrolling now
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Cleerly, Inc.
NCT IDNCT06112418ClinicalTrials.gov data as of Apr 2026
Target enrollment
7,500
Study length
about 5 years
Ages
55+
Locations
123 sites in AZ, CA, CO +29
About this study
Researchers are testing whether a Cleerly CAD Staging System-based care strategy reduces cardiovascular events compared with risk factor-based care in people at increased risk for heart disease but without symptoms. The trial will last 1825 days and involve approximately 7500 participants.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use The Cleerly CAD Staging System
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low15%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Body systems
Endocrinology